Psychopharmacology Books
Cambridge University Press Prescribers Guide Antidepressants
Book SynopsisThis spin-off from Stephen M. Stahl's new, completely revised, and fully updated sixth edition of the Prescriber's Guide covers the most important drugs in use today for treating depression.Table of ContentsIntroduction; List of icons; Agomelatine; Amisulpride; Amitriptyline; Amoxapine; Amphetamine (d); Amphetamine (d,l); Aripiprazole; Armodafinil; Asenapine; Atomoxetine; Brexpiprazole; Bupropion; Buspirone; Citalopram; Clomipramine; Cyamemazine; Desipramine; Desvenlafaxine; Dothiepin; Doxepin; Duloxetine; Escitalopram; Fluoxetine; Flupenthixol; Fluvoxamine; Iloperidone; Imipramine; Isocarboxazid; Ketamine; Lamotrigine; Lisdexamfetamine; Lithium; Lofepramine; Lurasidone; Maprotiline; Methylfolate (l); Methylphenidate (d); Methylphenidate (d,l); Mianserin; Milnacipran; Mirtazapine; Moclobemide; Modafinil; Nefazodone; Nortriptyline; Olanzapine; Paroxetine; Phenelzine; Protriptyline; Quetiapine; Reboxetine; Selegiline; Sertindole; Sertraline; Sulpiride; Tianeptine; Tranylcypromine; Trazodone; Triiodothyronine; Trimipramine; Venlafaxine; Vilazodone; Vortioxetine; Index by drug name; Index by use.
£56.99
Cambridge University Press Management of Complex Treatmentresistant
Book SynopsisThis full-color, practical handbook provides a concise, evidence-based psychopharmacological approach to the management of complex treatment-resistant psychotic disorders. Part I focuses uniquely on topics and strategies relevant to treating this challenging patient population. These approaches go beyond standard guidelines while adhering to research and clinically derived data. Part II provides a concise array of information regarding those classes of medications most commonly used when treating complex treatment-resistant psychotic disorders. Each medication guide contains sections including mechanisms of action, typical treatment response, monitoring, dosing and kinetics, medications to avoid in combination/warnings, and take-home pearls. Part III offers tips in brief appendix chapters for managing common issues ranging from loading lithium and valproic acid to the treatment of acute psychomotor agitation. An essential resource for psychiatrists, forensic clinicians, psychiatric trainees, and all mental health professionals involved with, or interested in, the treatment of challenging psychotic disorders.Trade Review'The book is clearly useful for medical students, residents, and young psychiatrists.' Michael Easton, Doody's NotesTable of ContentsPart I. Treatment Strategies: 1.01. Approaches to positive Psychotic symptoms; 1.02. Use of plasma levels in Antipsychotic and Mood Stabilizer treatment; 1.03. Advantages of long-acting injectable Antipsychotics; 1.04. Approach to Schizophrenia Spectrum treatment-resistant patients; 1.05. Approach to depressed or suicidal Schizophrenia Spectrum patients; 1.06. Approach to persistent aggression and violence in Schizophrenia Spectrum Disorders; 1.07. Approach to treatment of Bipolar Diathesis in Schizophrenia Spectrum patients; 1.08. Approach to Anxiety in Schizophrenia Spectrum patients; 1.09. Approach to Insomnia and Sleep Disturbance in Schizophrenia Spectrum disorders; 1.10. Approach to Psychosis in children and adolescents; 1.11. Electro-convulsive therapy and other Non-pharmacological treatments; 1.12. Approach to substance use disorders in Schizophrenia Spectrum Disorders; 1.13. Approaches to Behavioral Disturbances and Dementia and TBI patients; Part II. Medication Reference Tables: First-generation (Typical) Antipsychotics: 2.01. Chlorpromazine; 2.02. Fluphenazine; 2.03. Haloperidol; 2.04. Loxapine; 2.05. Perphenazine; 2.06. Thiothixene; 2.07. Trifluoperazine; Second-generation (Atypical) Antipsychotics: 2.08. Asenapine; 2.09. Clozapine; 2.10. Iloperidone; 2.11. Lumateperone; 2.12. Lurasidone; 2.13. Olanzapine; 2.14. Paliperidone; 2.15. Quetiapine; 2.16. Risperidone; 2.17. Ziprasidone; Dopamine Partial Agonist Antipsychotics (Arias): 2.18. Aripiprazole; 2.19. Brexpiprazole; 2.20. Cariprazine; Medications for Motor/Neurologic Adverse Effects: 2.21. Amantadine; 2.22. Benztropine; 2.23. Diphenhydramine; 2.24. Trihexyphenidyl; Mood Stabilizers: 2.25. Carbamazepine; 2.26. Lamotrigine ; 2.27. Lithium; 2.28. Valproic Acid; Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: 2.29. Citalopram; 2.30. Escitalopram; 2.31. Fluoxetine; 2.32. Fluvoxamine; 2.33. Paroxetine; 2.34. Sertraline: SSRI/5HT-1 Partial Agonist Antidepressants: 2.35. Vilazodone; 2.36. Vortioxetine; Serotonin/Norepinephrine Reuptake Inhibitor (SNRI) Antidepressants; 2.37. Desvenlafaxine; 2.38. Duloxetine; 2.39. Levomilnacipran; 2.40. Venlafaxine; Mixed Mechanism Antidepressants: 2.41. Bupropion; 2.42. Mirtazapine; 2.43. Trazodone; Tricyclic Antidepressants: 2.44. Amitriptyline; 2.45. Clomipramine; 2.46. Desipramine; 2.47. Doxepin; 2.48. Imipramine; 2.49. Nortriptyline; Monoamine Oxidase Inhibitor (MAOI) Antidepressants: 2.50. Isocarboxazid; 2.51. Moclobemide; 2.52. Phenelzine; 2.53. Transdermal Segeliline; 2.54. Tranylcypromine; Anxiolytics: 2.55. Alprazolam; 2.56. Buspirone; 2.57. Clonazepam; 2.58. Diazepam; 2.59. Hydroxyzine; 2.60. Lorazepam; Sedatives: 2.61. Diphenhydramine; 2.62. Eszopiclone; 2.63. Hydroxyzine; 2.64. Lorazepam; 2.65. Oxazepam; 2.66. Temazepam; 2.67. Zaleplon; 2.68. Zolpidem; Circadian Regulators: 2.69. Melatonin; 2.70. Ramelteon; 2.71. Tasimelteon; Stimulants: 2.72. Atomoxetine; 2.73. Dextroamphetamine; 2.74. Lisdexamphetamine; 2.75. Methylphenidate; 2.76. Mixed Amphetamine Salts: Histaminic Stimulants: 2.77. Armodafinil; 2.78. Modafinil; Cognitive Agents: 2.79. Dextromethorphan/quinidine; 2.80. Donepizil; 2.81. Galantamine; 2.82. Memantine; 2.83. Rivastigmine; Alpha2-adrenergic Agonists: 2.84. Clonidine; 2.85. Guanfacine; Appendices: 3.01. Optimal Antipsychotic Plasma Concentration Ranges; 3.02. Optimal Mood Stabilizer Plasma Concentration Ranges; 3.03. Formulas for QT Interval Correction; 3.04. Common Cytochrome P-450 Inducers and Inhibitors; 3.05. Management of Constipation; 3.06. Child-Pugh Hepatic Function Scoring; 3.07. Loading of Lithium and Valproic Acid; 3.08. Treatment of Prolactin Elevation; 3.09. A Select List of Foods High in Tyramine; 3.10. Medications that Present Risk for Serotonin Syndrome when Combined with MAOIs; 3.11. Selected Treatment of Psychomotor Agitation.
£41.99
Palgrave MacMillan UK The Bitterest Pills The Troubling Story of Antipsychotic Drugs
Book SynopsisA challenging reappraisal of the history of antipsychotics, revealing how they were transformed from neurological poisons into magical cures, their benefits exaggerated and their toxic effects minimized or ignored.Trade Review"This book will make an enormous contribution towards a more rational, transparent and ethical approach to the use of neuroleptic drugs. By implication it also offers up a strong argument for much wider choice for people in crisis, particularly the provision of minimal drug/drug-free systems of help and support, such as Soteria-type facilities and Open Dialogue. It is a must-read for all psychiatrists and mental health professionals, and its accessibility means that many survivors/service users and carers will find it a valuable ally in their fight for more humane and less harmful alternatives to psychiatric drug treatment." - Philip Thomas, University of Bradford, UK 'a meticulous, balanced history of antipsychotic drugs' - Nature 'All in all, this is a brilliantly clear-eyed, informative, well-referenced and at times disturbing book which should be essential reading for clinicians, policy-makers and patients alike.' - Psychosis: Psychological, Social and Integrative Approaches 'Joanna Moncrieff's courageous research continues to point out that the emperor, while dressed, is wearing the wrong clothes for the job.' - Therapy Today 'Psychiatrist Moncrieff [...] offers a refreshingly critical look at the motivation behind atypical antipsychotic drug use from the pharmaceutical standpoint as well as the pharmacological basis, or lack thereof, in some cases.' - Choice 'This schematic account cannot do justice to the tightness of the arguments and numerous illustrative examples with which Dr Moncrieff charts the all-important transition from the drug-centred to the disease-centred model and its adverse consequences.' - BrainTable of ContentsPreface 1. Cure or Curse? 2. Chlorpromazine 3. Magic Bullets 4. Building a House of Cards 5. The Phoenix Rises 6. Looking Where the Light is 7. The Patient's Dilemma 8. Antipsychotics as Chemical Cosh 9. Old and New Drug-Induced Problems 10. The First Tentacles 11. The Antipsychotic Epidemic 12. All is Not as it Seems
£41.84
Macmillan Learning Juliens Primer of Drug Action
Book Synopsis
£71.24
W. W. Norton & Company Embodied Psychedelic Therapy
£24.00
Bloomsbury Publishing PLC Treatments for Anxiety
Book SynopsisMyrna Chandler Goldstein, MA, has been a freelance writer and independent scholar for more than 30 years. She is the coauthor of Pain Management: Fact versus Fiction (Greenwood, 2022) and Dietary Supplements: Fact versus Fiction (Greenwood, 2020), among others.Mark A. Goldstein, MD, is the founding chief emeritus of the Division of Adolescent and Young Adult Medicine at Massachusetts General Hospital and Associate Professor of Pediatrics at Harvard Medical School. He is also the editor in chief of Current Pediatrics Reports.
£57.00
Guilford Publications The Therapists Guide to Psychopharmacology Third
Book SynopsisNow in a revised and updated third edition, this noted practitioner guide and text incorporates the latest knowledge about psychopharmacology and collaborative care. Therapists and counselors learn when and how to make medication referrals and how to address patients' questions about drug benefits, side effects, safety, and more. Organized around frequently encountered mental health disorders, the book explains how medications work (including what they can and cannot accomplish). Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. Written for optimal practical utility, the text features case examples, sample referral letters, checklists, and a glossary. New to This Edition *Chapter on the therapeutic relationship. *New separate chapter on bipolar disorder. *Expanded discussions of distinguishing psychiatric illness from normal distress, optimizing collaboration with psychiatrists, how mediTrade Review"All psychotherapists practicing today, whether independently or in community settings, must be informed about psychopharmacology. This superb book covers how to talk to patients and their families about medication and collaborate with prescribers. The third edition is up to date and exceptionally well written, and covers the diagnostic ground from anxiety and depression to psychosis and cognitive disorders. I cannot think of a book that better achieves its purpose of educating non-MD mental health practitioners and graduate students to be as helpful as possible to their patients who are taking, or may need, psychoactive medication."--Stanley B. Messer, PhD, Distinguished Professor Emeritus and former Dean, Graduate School of Applied and Professional Psychology, Rutgers, The State University of New Jersey "The third edition of this guide gives psychotherapists both a systemic conceptual framework and the latest science about psychotropic medications and how they work. The distinguished trio of Patterson, Griffith, and Edwards emphasize the essential need for collaboration between therapists and prescribing clinicians. This book provides everything you need to know about medications' effects on the brain and behavior when used in conjunction with behavioral interventions for common psychiatric disorders."--Susan H. McDaniel, PhD, ABPP, Dr. Laurie Sands Distinguished Professor of Families and Health, University of Rochester Medical Center “This book is a gem. It is the best book that I’ve seen that provides beginning and seasoned nonmedical clinicians with essential information about psychopharmacology with a spectrum of mental health conditions. What sets this book apart is the authors' use of a systems and collaborative care framework that includes patients and key family members as valuable resources. Written in an exceptionally practical and accessible style with wonderful case illustrations, the book is a superb reference for clinicians working in integrated healthcare and private practice settings. I highly recommend this volume as an excellent basic teaching text for graduate students across mental health disciplines."--John S. Rolland, MD, MPH, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine "This book is extremely well suited to those who have no prior knowledge of psychopharmacology or wish to build on their existing knowledge. The text is a professor's dream--is clearly laid out, builds sequentially on previous learning, and incorporates the latest developments in the field. This is one of those rare publications that students in the helping professions should keep on their shelves long after graduation. I have relied on this book over the years in a variety of academic and clinical settings, and remain impressed by its clarity, practicality, and relevance."--Sarah A. Bond, PsyD, Solana Beach, California-Provides a wealth of information to individuals in the helping professions to assist them in better understanding the link between medications and therapy for a variety of diagnoses....This text is an exceptional reference guide for the therapist. The information provided is explained in a straightforward format and is easy to understand and use in one's work with families. In addition, this book would be a wonderful faculty reference or text for students in courses that focus on psychological disorders. (on the first edition)--Family Journal, 10/1/2007ƒƒThe book offers practical guidance to providers--information that can be used both to influence therapists' work and to pass along to their clients....A valuable resource. (on the first edition)--PsycCRITIQUES, 8/15/2007ƒƒA clear, understandable and helpful book for the nonphysician wishing to be more conversant within this field. (on the first edition)--Child and Family Behavior Therapy, 6/1/2007ƒƒThe authors have written one of the best books available on psychopharmacology by providing detailed information in a user-friendly format for all mental health clinicians....Academics and practicing clinicians will, without a doubt, keep this book within reach for daily use. I will recommend this book to all of my colleagues….5 Stars! (on the first edition)--Doody's Review Service, 7/27/2007ƒƒA must-have text for clinicians, and will help them provide the best standard of care to their patients and clients. (on the second edition)--Metapsychology Online Reviews, 8/30/2011Table of ContentsI. The Mind–Body Connection 1. How the Brain Works: A Basic Sketch 2. How Psychotropic Drugs Work II. Psychiatric Disorders and Their Treatment 3. Depression 4. Bipolar Disorder 5. Anxiety Disorders 6. Schizophrenia and Other Psychoses 7. Cognitive Disorders 8. Alcoholism and Substance Abuse 9. Physical Health and Illness 10. Special Populations III. Creative Collaboration 11. The Therapeutic Relationship 12. Effective Referrals 13. Sharing Care 14. Strengthening Bonds Glossary References Index
£36.09
Guilford Publications The Therapists Guide to Psychopharmacology Third
Book SynopsisNow in a revised and updated third edition, this noted practitioner guide and text incorporates the latest knowledge about psychopharmacology and collaborative care. Therapists and counselors learn when and how to make medication referrals and how to address patients' questions about drug benefits, side effects, safety, and more. Organized around frequently encountered mental health disorders, the book explains how medications work (including what they can and cannot accomplish). Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. Written for optimal practical utility, the text features case examples, sample referral letters, checklists, and a glossary. New to This Edition *Chapter on the therapeutic relationship. *New separate chapter on bipolar disorder. *Expanded discussions of distinguishing psychiatric illness from normal distress, optimizing collaboration with psychiatrists, how mediTrade Review"All psychotherapists practicing today, whether independently or in community settings, must be informed about psychopharmacology. This superb book covers how to talk to patients and their families about medication and collaborate with prescribers. The third edition is up to date and exceptionally well written, and covers the diagnostic ground from anxiety and depression to psychosis and cognitive disorders. I cannot think of a book that better achieves its purpose of educating non-MD mental health practitioners and graduate students to be as helpful as possible to their patients who are taking, or may need, psychoactive medication."--Stanley B. Messer, PhD, Distinguished Professor Emeritus and former Dean, Graduate School of Applied and Professional Psychology, Rutgers, The State University of New Jersey "The third edition of this guide gives psychotherapists both a systemic conceptual framework and the latest science about psychotropic medications and how they work. The distinguished trio of Patterson, Griffith, and Edwards emphasize the essential need for collaboration between therapists and prescribing clinicians. This book provides everything you need to know about medications' effects on the brain and behavior when used in conjunction with behavioral interventions for common psychiatric disorders."--Susan H. McDaniel, PhD, ABPP, Dr. Laurie Sands Distinguished Professor of Families and Health, University of Rochester Medical Center “This book is a gem. It is the best book that I’ve seen that provides beginning and seasoned nonmedical clinicians with essential information about psychopharmacology with a spectrum of mental health conditions. What sets this book apart is the authors' use of a systems and collaborative care framework that includes patients and key family members as valuable resources. Written in an exceptionally practical and accessible style with wonderful case illustrations, the book is a superb reference for clinicians working in integrated healthcare and private practice settings. I highly recommend this volume as an excellent basic teaching text for graduate students across mental health disciplines."--John S. Rolland, MD, MPH, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine "This book is extremely well suited to those who have no prior knowledge of psychopharmacology or wish to build on their existing knowledge. The text is a professor's dream--is clearly laid out, builds sequentially on previous learning, and incorporates the latest developments in the field. This is one of those rare publications that students in the helping professions should keep on their shelves long after graduation. I have relied on this book over the years in a variety of academic and clinical settings, and remain impressed by its clarity, practicality, and relevance."--Sarah A. Bond, PsyD, Solana Beach, California-Provides a wealth of information to individuals in the helping professions to assist them in better understanding the link between medications and therapy for a variety of diagnoses....This text is an exceptional reference guide for the therapist. The information provided is explained in a straightforward format and is easy to understand and use in one's work with families. In addition, this book would be a wonderful faculty reference or text for students in courses that focus on psychological disorders. (on the first edition)--Family Journal, 10/1/2007ƒƒThe book offers practical guidance to providers--information that can be used both to influence therapists' work and to pass along to their clients....A valuable resource. (on the first edition)--PsycCRITIQUES, 8/15/2007ƒƒA clear, understandable and helpful book for the nonphysician wishing to be more conversant within this field. (on the first edition)--Child and Family Behavior Therapy, 6/1/2007ƒƒThe authors have written one of the best books available on psychopharmacology by providing detailed information in a user-friendly format for all mental health clinicians....Academics and practicing clinicians will, without a doubt, keep this book within reach for daily use. I will recommend this book to all of my colleagues….5 Stars! (on the first edition)--Doody's Review Service, 7/27/2007ƒƒA must-have text for clinicians, and will help them provide the best standard of care to their patients and clients. (on the second edition)--Metapsychology Online Reviews, 8/30/2011Table of ContentsI. The Mind–Body Connection 1. How the Brain Works: A Basic Sketch 2. How Psychotropic Drugs Work II. Psychiatric Disorders and Their Treatment 3. Depression 4. Bipolar Disorder 5. Anxiety Disorders 6. Schizophrenia and Other Psychoses 7. Cognitive Disorders 8. Alcoholism and Substance Abuse 9. Physical Health and Illness 10. Special Populations III. Creative Collaboration 11. The Therapeutic Relationship 12. Effective Referrals 13. Sharing Care 14. Strengthening Bonds Glossary References Index
£54.14
Simon & Schuster Ltd The Drugs That Changed Our Minds
Book Synopsis'Poignant and lyrical...Slater's experience makes her a convincing travel guide into the history, creation and future of psychotropics.' – The New York Times Book Review A groundbreaking and revelatory story of the psychotropic drugs that have shaped our minds and our reality. As our approach to mental illness has oscillated from biological to psychoanalytical and back again, so have our treatments. With the rise of psychopharmacology, an ever-increasing number of people throughout the globe are taking a psychotropic drug, yet nearly seventy years after doctors first began prescribing them, we still don’t really know exactly how or why they work – or don’t work – on what ails our brains. In The Drugs that Changed Our Minds, Lauren Slater offers an explosive account not just of the science but of the people – inventors, detractors and consuTrade Review'A profound and essential look at a phenomenon of our times. Meticulously researched, The Drugs That Changed Our Minds is also a deeply moving personal investigation into the drugs so many of us rely upon for our survival. Slater is much more than a trusted guide: she’s a brave and eloquent companion who doesn’t shy away from controversy. You’ll be talking and thinking about The Drugs That Changed Our Minds long after you’ve read it.' -- Terri Cheney, author of the New York Times bestseller Manic'In this ambitious undertaking, psychologist Slater applies vigorous research and intimate reflection to the issues involved with treating mental suffering...highly compelling' * Kirkus *'Weaving together the history of psychopharmacology and her personal experience as a patient, Slater offers readers a candid and compelling glimpse at life on psychiatric drugs and the science behind them. Intriguing and instructive.' * Booklist *'Psychologist Slater runs through the checkered history of psychopharmacology and mental illness treatments while sharing her own battle with depression and medication in this ambitious work . . . Slater offers many insights here, and her moving personal story truly illuminates the triumphs and shortcomings of psychotropic drugs.' * Publishers Weekly *'Slater, a writer and psychologist, takes a skeptical yet compassionate approach to the history of Psychopharmacology…the result is a vivid and thought-provoking synthesis' -- Lidija Haas * Harper’s Magazine *'the messy history and brave future of psychotropic drugs...Slater sifts through the remedies one in five Americans relies on but knows little about – even breaking into an abandoned asylum in her quest' * O Magazine *'A capacious and rigorous history...The real strength of this book comes from Slater’s very particular position. She is patient and psychologist, part of the first wave of people who were prescribed Prozac in the 1980s.' * New York Times *
£17.09
Bloomsbury Publishing Plc Pill
Book SynopsisObject Lessons is a series of short, beautifully designed books about the hidden lives of ordinary things. You are what you eat. Never is this truer than when we use medications, from beta blockers and aspirin to Viagra and epiduralsand especially psychotropic pills that transform our minds as well as our bodies. Meditating on how modern medicine increasingly measures out human identity not in T. S. Eliot's proverbial coffee spoons but in 1mg-, 5mg-, or 300mg-doses, Pill traces the uncanny presence of psychiatric pills through science, medicine, autobiography, television, cinema, literature, and popular music. Robert Bennett reveals modern psychopharmacology to be a brave new world in which human identities thoughts, emotions, personalities, and selves themselvesare increasingly determined by the extraordinary powers of seemingly ordinary pills.Object Lessons is published in partnership with an essay series in The Atlantic.Trade ReviewBennett is great … in showing how the pill has pervaded popular culture and popular thinking. He coins the genre title of “psychopharmacological thriller,” a mouthful but apt: the film or TV show about not just drugs, but also their making, distribution, and effects. Under this last head, he unleashes a brilliant set piece on Carrie Mathison (played so well by Claire Danes in Homeland.) * The Philadelphia Inquirer *Robert Bennett's Pill, another volume in Bloomsbury's fine Object Lessons series … effectively looks at all areas of the history, understanding, and application of pills as maintenance tools (or presumed cures) in psychopharmacology … It's this careful, methodical journey Bennett takes through these medications and their effects as manifested through popular culture that makes Pill an effective, compelling book … Pill succinctly and comprehensively charts the enigmatic relationship humanity has had with wonder drugs of all sorts, particularly here Thorazine through Adderall. [Bennett] suggests, carefully, and with touching immediacy (especially through the final personal chapter), that there's still work to be done as we understand both the blessings and the curses of these drugs. * PopMatters *In this wide-ranging and readable book, Robert Bennett shows the many ways that our pills are us. Pill is a cautionary tale about putting our faith in easy cures, and necessary reading for anyone who wants to better understand our complex, anxious, and uncertain times. * Rachel Adams, Professor of English and Comparative Literature, Columbia University, and author of Raising Henry: A Memoir of Motherhood, Disability, and Discovery (2013) *Adept in its understanding of the relationship between pharmacology and culture, this book incisively demonstrates how psychotropic drugs engineer the modern self. Pill doesn’t invite us to ask our doctors about Zoloft but rather to ask ourselves how Zoloft defines us as individuals. * Lorenzo Servitje, Assistant Professor of Literature and Medicine, Lehigh University, USA, and co-editor of The Walking Med: Zombies and the Medical Image (2016) *Table of ContentsIntroduction: Pharmageddon 1 Thorazine (C17H19ClN2S): The Psychopharmacological Revolution 2 Valium (C16H13ClN2O): The Psychopharmacology of Everyday Life 3 Lithium (Li2CO3): The Psychopharmacological Thriller 4 Prozac (C17H18F3NO): Existential Quagmires 5 Adderall ((C9H13N)2H2SO4 + (C9H13N)2H2SO4 + (C9H13N)2C6H10O8 + (C9H13N)C4H7NO4H2O): Psychopharmacology Unbound Coda: Waiting for Brad Pitt Acknowledgements List of Figures Notes Index
£9.49
Nootropics Zone Nootropics: Unlocking Your True Potential With
Book Synopsis
£9.36
Nova Science Publishers Inc Clinical Aspects of Psychopharmacology in
Book Synopsis
£163.19
American Psychiatric Association Publishing Clinical Manual of Drug Interaction Principles for Medical Practice
Book SynopsisDrug interactions have become a significant iatrogenic complication, with as many as 5% of hospitalizations and 7,000 deaths annually attributable to drug-drug interactions in the United States. There are several reasons these numbers have increased. First, many new medications have been brought to market in recent years. Second, advances in medical care have resulted in increased longevity and more elderly patients than ever before—patients who are more likely to be following polypharmacy regimens. Population patterns in the U.S. have amplified this trend, with aging baby boomers swelling the patient pool and demanding treatment with medications advertised on television and in print. Fortunately, drug interactions can be prevented with access to current, comprehensive, reliable information, and the Clinical Manual of Drug Interaction Principles for Medical Practice provides just that in a user-friendly format psychiatry clinicians (including residents and nurses) and forensics experts will find indispensable. With this new edition, the book has evolved from "Concise Guide" to "Clinical Manual" and offers the expanded coverage and features healthcare providers need to keep up with this critical field. The book is well organized, with major sections on metabolism; cytochrome P450 enzymes; drug interactions by medical specialty; and practical matters, such as the medicolegal implications of drug-drug interactions and how to retrieve and review the literature. In the section on P450 enzymes, each chapter addresses what the individual enzyme does and where, its polymorphisms, and drugs that inhibit or induce activity. Each chapter also includes extensive references and study cases to help the reader understand and contextualize the information. A number of additional features enhance the book's scope and utility: • The book boasts the very latest information in the area of drug metabolism, transport, and interaction.• The chapter on P-glycoprotein (a drug transporter) was expanded from the last edition to include a broader array of transport mechanisms.• The highest ethical standard was adhered to in the development of this volume, which was not supported in any way by pharmaceutical makers or distributors. All eight contributors to this excellent resource are experts in the fields they have addressed, and clinicians can trust that the information contained in the Manual reflects the very latest research. This exceptionally practical manual is essential to maintaining the highest standard of care.Trade ReviewThe wrong mixture of over the counter drugs can be fetal, and doctors and pharmacists must be aware of these lethal combos. "Clinical Manual of Drug Interaction Principles for Medical Practice" is a scholarly work discussing this very real possibility that can be prevented with the right research and foresight. With the hundreds upon hundreds of new drugs entering the market every year, the research into this subject is now invaluable, as it could save thousands of lives. Filled with complete and comprehensive and up to date research on drug interaction, "Clinical Manual of Drug Interaction Principles" is strongly recommended for community and college library medicine collections. * The Midwest Book Review *As a resident physician in a combined internal medicine/psychiatry residency program, I found this book extremely helpful. It serves as a great source when caring for patients with multiple medical problems coupled with mental illness.The large amount of information in this book justifies its change from a concise guide to a clinical manual. * Doddy Enterprises *Table of ContentsContributorsPrefaceAcknowledgmentsPART I: Introduction and Basic Pharmacology of Metabolic Drug InteractionsChapter 1. Introduction to Drug Interactions and to This Clinical ManualChapter 2. Definitions and Phase I MetabolismChapter 3. Metabolism in Depth: Phase IIChapter 4. TransportersPART II: P450 EnzymesIntroduction to Part IIChapter 5. 2D6Chapter 6. 3A4Chapter 7. 1A2Chapter 8. 2C9Chapter 9. 2C19Chapter 10. 2E1Chapter 11. 2A6, 2B6, and 2C8PART III: Drug Interactions by Medical SpecialtyChapter 12. Gynecology: Oral Contraceptives Chapter 13. Internal MedicineChapter 14. Infectious DiseasesChapter 15. NeurologyChapter 16. OncologyChapter 17. Pain Management I: Nonnarcotic AnalgesicsChapter 18. Pain Management II: Narcotic AnalgesicsChapter 19. PsychiatryChapter 20. Transplant Surgery and Rheumatology: ImmunosuppressantsPART IV: Practical MattersChapter 21. GuidelinesChapter 22. Medicolegal Implications of Drug-Drug InteractionsChapter 23. How to Retrieve and Review the LiteratureAppendix: Tables of Drug Interaction PharmacokineticsIndex
£53.10
American Psychiatric Association Publishing The Evidence-Based Guide to Antipsychotic Medications
Book Synopsis The Evidence-Based Guide to Antipsychotic Medications is designed to provide both clinicians and residents with focused, comprehensive, and clinically relevant information regarding the use of antipsychotic medications to treat a broad range of psychiatric conditions—from mood and anxiety disorders to substance abuse, personality disorders, and schizophrenia. The volume editor is a renowned psychiatrist and author with more than 25 years of experience in both clinical and research settings diagnosing and treating patients with mood and psychotic disorders. In addition, each of the volume's 13 contributors is an expert with many years of clinical experience to draw on.The book is down-to-earth and reader-friendly and is structured for maximal utility in both coverage and format: • Key Clinical Points cap each chapter, synthesizing and summarizing the knowledge you can take away, and serving both as a refresher for those using the book as a reference and as a study aid to master the material.• Both FDA-approved and off-label use of antipsychotic medications are addressed, reflecting the reality of clinical practice on the front lines.• Use of antipsychotic medications in both the pediatric and geriatric populations, a potentially controversial subject, is addressed in a nonsensational, straight-forward manner.• The Appendixes provide a wealth of information in tabular format, including drug tables (names, strengths, formulations, pharmacokinetics, and dosing); advice on initiating and monitoring antipsychotic medications; common side effects and their management; and special considerations for use during pregnancy and breastfeeding. The Evidence-Based Guide to Antipsychotic Medications is the first in a new series that strives to take evidence-based psychiatry from gold standard to standard practice. Scientifically up-to-date and rigorous, yet accessible and easy to understand, this volume stands alone as an indispensable resource on the topic.Trade ReviewThis book is an excellent resource for clinicians treating patients withpsychiatric disorders. Summing Up: Highly recommended. Graduate students through professionals/practitioners. * CHOICE *This is a good, practical, evidence-based clinical approach to the use of antipsychotic medications for a variety of disorders and in special populations. The pages are of high quality paper that resists tearing and makes annotation easy. The tables and bullet-point summaries are very useful in comprehending the material. I appreciated the appendixes, which are a useful review of some key core points in the usage of antipsychotics. This is a good evidence-based guide that any clinician can pick up and use - and it is reasonably priced. -- Steve Paschos, M.D. * Doody Enterprises, Inc. *Table of ContentsContributorsAcknowledgmentsDisclaimerChapter 1. IntroductionChapter 2. Schizophrenia and Schizoaffective DisorderChapter 3. Mood and Anxiety DisordersChapter 4. Personality DisordersChapter 5. Substance Abuse DisordersChapter 6. Use of Antipsychotics in Children and AdolescentsChapter 7. Use of Antipsychotics in Geriatric PatientsChapter 8. Use of Antipsychotics in Medically Ill PatientsAppendix 1: Names, Strengths, and Formulations of First- and Second-Generation AntipsychoticsAppendix 2: Pharmacokinetics of First- and Second- Generation AntipsychoticsAppendix 3: Dosing and Administration of First- and Second-Generation Antipsychotics in SchizophreniaAppendix 4: Medical Workup When Initiating and Continuing First- and Second-Generation AntipsychoticsAppendix 5: Medical Workup When Initiating and Continuing ClozapineAppendix 6: Use of First- and Second-Generation Antipsychotics for Agitation Due to PsychosisAppendix 7: Side Effects of Commonly Used AntipsychoticsAppendix 8: Management of Treatment-Emergent Side Effects of Antipsychotic MedicationsAppendix 9: Use of First- and Second-Generation Antipsychotics in Pregnancy and LactationIndex
£53.10
American Psychiatric Association Publishing Manual of Clinical Psychopharmacology for Nurses
Book Synopsis Manual of Clinical Psychopharmacology for Nurses offers a holistic approach to psychopharmacological prescribing from a nursing perspective and is the only text designed especially for Psychiatric Mental Health Advanced Practice Registered Nurses (P.M.H.-A.P.R.N.s). The Manual is grounded in the belief that given their nursing background and their personalized approach to the individual, P.M.H.-A.P.R.N.s are uniquely qualified to offer symptom-based treatment within the context of an individual's medical and psychological care. A comprehensive resource for advanced practice nurses, mental health practitioners, general practitioners, and consumers, this book possesses many useful features, including the following: • A logical, easy-to-use format that guides the reader through the most common psychiatric conditions, presenting the diagnostic criteria and neurobiology of the relevant disorder, pharmacological choices and recommendations on monitoring, side effects to consider, and treatment of special populations, including those with medical illnesses.• A special chapter devoted to culturally sensitive psychopharmacology that offers information on the role of culture in mental health, wellness, and illness and provides culturally sensitive assessment techniques and other treatment strategies PMH nurses can use to minimize stigma; address health care disparities; and improve patient adherence, satisfaction, and outcomes.• A chapter that addresses complementary and alternative pharmacotherapies—vital because a significant percentage of patients may be using herbal preparations, which present serious implications for the prescribing clinician.• Appendices covering drug dosing equivalencies, pharmacogenetics, psychiatric rating scales, and other helpful resources. The core philosophy of the advanced practice nursing field is that health care should be individualized, focusing not only on patients' conditions but also on the effects those conditions have on patients' lives and the lives of their families. The Manual of Clinical Psychopharmacology for Nurses offers readers the most current information on psychopharmacological treatment in an accessible, easy-to-use format grounded in the principles and practices of holistic nursing.Table of ContentsContributorsForewordPrefaceChapter 1. Introduction to Clinical Psychopharmacology for NursesPART I: Psychopharmacological Treatment and Management of Psychiatric DisordersChapter 2. Anxiety DisordersChapter 3. Depressive DisordersChapter 4. Bipolar DisordersChapter 5. Psychotic DisordersChapter 6. Attention-Deficit/Hyperactivity and Autistic Spectrum DisordersChapter 7. Substance Use DisordersChapter 8. Sleep-Wake DisordersChapter 9. Trauma and Posttraumatic Stress DisorderChapter 10. Delirium and DementiaPART II: Special Issues in Clinical PsychopharmacologyChapter 11. Psychopharmacology in Psychiatric EmergenciesChapter 12. Management of Metabolic Side Effects of Psychotropic MedicationsChapter 13. Complementary and Alternative PharmacotherapiesChapter 14. Culturally Sensitive PsychopharmacologyPART III: AppendixesAppendix 1: Approximate Psychotropic Drug Dose EquivalenciesAppendix 2: Psychotropic and Other Medications Influenced by the Cytochrome P450 (CYP) SystemAppendix 3: Psychopharmacogenetic Variations: Implications for PracticeAppendix 4: Psychiatric Rating ScalesAppendix 5: Online ResourcesIndex
£50.40
American Psychiatric Association Publishing The American Psychiatric Publishing Textbook of
Book Synopsis The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable and comprehensive resource for clinicians and trainees who prescribe psychotropic medications. Updated to reflect the new DSM-5 classification, this revised Fifth Edition maintains the user-friendly structure of its predecessors while offering in-depth coverage of the latest research in pharmacological principles, classes of drugs, and psychiatric disorders. Introductory chapters provide a theoretical grounding in clinical applications, with topics ranging from neurotransmitters to brain imaging in psychopharmacology. The bulk of the book is devoted to various classes of drugs, including antidepressants, anxiolytics, antipsychotics, mood stabilizers, and other agents, with each class divided into chapters on specific drugs—either new or revised to include the latest findings and trends. Finally, the section on psychopharmacological treatment addresses evidence-based principles of clinical care for the full spectrum of mental disorders and conditions—from depression to chronic pain—as well as for specific populations and circumstances—from children and adolescents to psychiatric emergencies—offering information on topics such as medication selection, combination and maintenance dosing regimens, monitoring and management of side effects, and strategies for optimizing treatment response. The book's beneficial features are many: • The section on principles of pharmacology has been revised and reorganized to incorporate recent discoveries from the fields of neurobiology, genetics, brain imaging, and epidemiology.• History and discovery, structure–activity relationships, pharmacological profiles, pharmacokinetics and disposition, mechanisms of action, indications and efficacy, side effects and toxicology, and drug–drug interactions are addressed for each agent. This consistent structure places the desired information at the clinician's fingertips and facilitates study for trainees.• Coverage of drugs approved since the last edition is thorough, encompassing new antidepressants (e.g., vortioxetine), new antipsychotics (e.g., cariprazine), and agents on the clinical horizon (e.g., ketamine).• More than 180 tables and graphs present critically important data in an accessible way. A work of uncommon scientific rigor and clinical utility, The American Psychiatric Association Publishing Textbook of Psychopharmacology provides state-of-the-art information on both the principles and the practice of psychopharmacological treatment of psychiatric disorders.Trade ReviewThis comprehensive, up-to-date reference on present day psychotropics thoroughly reviews the basics of psychopharmacology and individual drugs. The chapters on treatment tend to be a bit thin, although they cover all the evidence-based research. Unfortunately, while these chapters cover the basic "must know" information, they do not help with the management of the many complicated patients we encounter on a daily basis. The useful appendix at the end of the book covers both approved and off-label uses of various medications including dosing. -- Michael Easton, MD(Rush University Medical Center) * Doody *Table of ContentsContributorsIntroduction Part I: Principles of Pharmacology Chapter 1. Basic Principles of Molecular Biology and GenomicsChapter 2. NeurotransmittersChapter 3. GeneticsChapter 4. PsychoneuroendocrinologyChapter 5. Brain–Immune System InteractionsChapter 6. PharmacokineticsChapter 7. Brain Imaging in Psychopharmacology Part II: Classes of Psychiatric Treatments Antidepressants and Anxiolytics Chapter 8. Monoamine Oxidase InhibitorsChapter 9. TricyclicsChapter 10. FluoxetineChapter 11. SertralineChapter 12. ParoxetineChapter 13. FluvoxamineChapter 14. CitalopramChapter 15. Trazodone and NefazodoneChapter 16. VortioxetineChapter 17. MirtazapineChapter 18. BupropionChapter 19. VenlafaxineChapter 20. Duloxetine, Milnacipran, and LevomilnacipranChapter 21. KetamineChapter 22. BenzodiazepinesChapter 23. Buspirone Antipsychotics Chapter 24. Classic AntipsychoticsChapter 25. ClozapineChapter 26. OlanzapineChapter 27. QuetiapineChapter 28. Risperidone and PaliperidoneChapter 29. AripiprazoleChapter 30. ZiprasidoneChapter 31. AsenapineChapter 32. IloperidoneChapter 33. LurasidoneChapter 34. CariprazineChapter 35. Drugs to Treat Extrapyramidal Side EffectsDrugs for Treatment of Bipolar DisorderChapter 36. LithiumChapter 37. Valproate BowdenChapter 38. CarbamazepineChapter 39. GabapentinChapter 40. LamotrigineChapter 41. Topiramate Other Agents Chapter 42. Agents for Cognitive DisordersChapter 43. Sedative-HypnoticsChapter 44. Psychostimulants and Wakefulness-Promoting AgentsChapter 45. Neurostimulation Part III: Psychopharmacological Treatment Chapter 46. Treatment of DepressionChapter 47. Treatment of Bipolar DisorderChapter 48. Treatment of Anxiety and Related DisordersChapter 49. Treatment of SchizophreniaChapter 50. Treatment of Substance-Related DisordersChapter 51. Treatment of Personality DisordersChapter 52. Treatment of Eating DisordersChapter 53. Treatment of InsomniaChapter 54. Treatment of Chronic PainChapter 55. Treatment of Child and Adolescent DisordersChapter 56. Treatment During Late LifeChapter 57. Psychopharmacology During Pregnancy and LactationChapter 58. Treatment of Psychiatric EmergenciesChapter 59. Treatment of Agitation and Aggression in the Elderly
£312.53
Oxford University Press Inc Psychopharmacology
Book SynopsisUnique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies, Psychopharmacology is appropriate for undergraduates studying the relationships between the behavioral effects of psychoactive drugs and their mechanisms of action. BL Chapter-opening vignettes foster student engagement BL Up-to-date and outstanding coverage of current research BL Breakout boxes present novel, and, in some cases, controversial topics for special discussion. Box themes include History of Psychopharmacology; Pharmacology in Action; Clinical Applications; Of Special Interest; and The Cutting Edge BL The book is extensively illustrated with full-color photographs and line art depicting important concepts and experimental data BL Section Summaries highlight key concepts from the section of text just read BL Chapter-ending Recommended Readings offer suggestions for further study BL Enhanced e-Book provides an interactive learning pathway through the content BL End-of-chapter study questions to further aid students Meyer, Psychopharmacology and it's accompanying enhanced ebook provide engaging features like self-study questions, and clinical case studies, cutting edge research, and applied pharmacology to keep students focused on the content, while providing the scientific depth, breadth, and rigor required for the course.
£139.99
American Academy of Pediatrics Pediatric Psychopharmacology for Primary Care
Book SynopsisCompletely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.This simple, systematic approach defines discrete levels of psychotropics and spells out group-specific roles and responsibilities in accord with AAP policies. Plus, an included digital tool offers instant access to authoritative answers on specific conditions and medications.Topics include Conceptual framework for prescribing psychotropic drugs Medications for specific diagnoses: ADHD, Anxiety, and Depression US Food and Drug Administration-Approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful Trade Review“This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer.” — Sam Kohn, MD, FAAP, Asheville Children's Medical Center, NC, Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018“This is an excellent resource and I am confident primary care clinicians will find it incredibly helpful in their practice. This edition contains updated guidelines and prescribing regulations and provides online access to additional resources and information.” — Maria Alcocer Alkureishi, MD, University of Chicago Pritzker School of MedicineTable of Contents Introduction Part 1—Conceptual Framework Chapter 1—Conceptual Framework for Prescribing Psychotropic Part 2—Practical Guidance Chapter 2—Assessment Chapter 3—Prescribing Medications: Getting Started Part 3—Group 1 Medications for Specific Diagnoses: ADHD, Anxiety, and Depression Chapter 4—Group 1 Medications for Attention-Deficit/Hyperactivity Disorder Chapter 5—Group 1 Medications for Anxiety and Depression Part 4—Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications Chapter 6—Group 2 Medications: Antipsychotics and Mood Stabilizer Chapter 7—Group 3 Medications Part 5—Advanced Topics Chapter 8—What to Do When Treatment Is Not Successful Appendixes Index
£82.45
Nova Science Publishers Inc Clinical Aspects of Psychopharmacology in
Book Synopsis
£166.49
American Psychiatric Association Publishing Prescribing Together: A Relational Guide to
Book SynopsisWhat if, rather than acting only as dispensers of medication, mental health clinicians and primary care clinicians treating mental disorders were also collaborators with patients in the prescribing relationship? It's a simple but profound shift in how to think about approaching psychopharmacology, and in Prescribing Together, Warren Kinghorn and Abraham Nussbaum argue that this sort of human-to-human relationship-building is critical to prescribing more effectively and to achieving health equity. While many other books have focused on what to prescribe for given conditions, this volume is more concerned with how to prescribe: how to talk to patients about medications, how to understand the cultural and social factors that affect how both clinicians and patients relate to medication, and how to build trust in the relationship. Each chapter offers a practical introduction to at least one key concept or skill, from cultural formation and structural competency to medication concordance and deprescribing. Profiles, rich in personal anecdotes, of a diverse group of accomplished clinicians serve as an engaging, real-life foundation for evidence-based strategies for building strong alliances in the context of 13 mental disorder categories, including: • Schizophrenia• Bipolar disorder• Major depressive disorder• Generalized anxiety disorder• Neurocognitive disorders• Borderline personality disorder In drawing a contrast between a dispenser and a collaborator model, Prescribing Together encourages clinicians not just to look at their patients, but to look with them at their lived experience, to understand their stories and interpersonal and social contexts—all with the aim of returning agency to patients and empowering them to set meaningful goals and to be active particpants in their own flourishing.Trade ReviewThis is an important and useful contribution to the field. As prescribing moves more and more towards an algorithmic approach, this book provides an important reminder that the doctor-patient relationship is every bit as important as the pharmacological treatment. It reminds us that prescribing does not exist in a bubble, and that medication treatment is itself a form of psychotherapy. The book draws heavily on the psychodynamic pharmacology work of David Mintz but also extends his work to other areas. It is written in an easily accessible manner, and I recommend it to all new psychiatric prescribers. -- Zachary Cohen Hommer, MD * Doody *Table of ContentsAbout the AuthorsAcknowledgmentsChapter 1. Introduction: From Dispensers to CollaboratorsChapter 2. Relationship MattersChapter 3. Prescribing AlliancesChapter 4. Peak Performance: Prescribing in the Context of Attention-Deficit/Hyperactivity DisorderChapter 5. Visions and Voices: Prescribing in the Context of Schizophrenia and Other Psychotic DisordersChapter 6. Stabilization Forces: Prescribing in the Context of Bipolar DisorderChapter 7. Frayed Edges: Prescribing in the Context of Depressive and Anxiety DisordersChapter 8. Unwelcome Strangers: Prescribing in the Context of Obsessive-Compulsive and Related DisordersChapter 9. Building Peace: Prescribing in the Context of Trauma- and Stressor-Related DisordersChapter 10. When the Body Speaks: Prescribing in the Context of Somatic DistressChapter 11. Befriending the Body: Prescribing in the Context of Eating DisordersChapter 12. Getting Clean: Prescribing in the Context of Substance Use DisordersChapter 13. Knowing and Being Known: Prescribing in the Context of Neurocognitive DisordersChapter 14. Strong Emotions: Prescribing in the Context of Borderline Personality DisorderEpilogue: From Fixing to Attending Appendix: Alliance Measures
£39.95
American Psychiatric Association Publishing Clinical Manual of Child and Adolescent
Book SynopsisUpdated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology not only examines the evidence for treating mental health disorders in younger patients but also illuminates how clinical trials of various methodologies can inform different aspects of clinical practice. Organized by DSM-5-TR diagnosis rather than drug class, this clinically accessible volume offers an exhaustive analysis of the use of psychotropic agents in disorders that include • Attention-deficit/hyperactivity disorder• Depressive disorders• Autism spectrum disorder• Early schizophrenia and psychotic illnesses• Eating disorders Comprehensive medication tables allow for easy reference of dosing, side effects, and tips for management. Additionally, key points at the conclusion of each chapter summarize essential information for treating clinicians. With a depth of information unmatched by any other guide, this new edition of the Clinical Manual of Child and Adolescent Psychopharmacology is an indispensable desktop reference for clinicians working with young patients.Table of ContentsForewordPrefaceChapter 1. Developmental Aspects of Pediatric PsychopharmacologyChapter 2. Attention-Deficit/Hyperactivity DisorderChapter 3. Disruptive Behavior Disorders and AggressionChapter 4. Anxiety DisordersChapter 5. Major Depressive DisorderChapter 6. Bipolar DisordersChapter 7. Autism Spectrum DisorderChapter 8. Tic DisordersChapter 9. Early-Onset Schizophrenia and Psychotic IllnessesChapter 10. Eating Disorders
£59.40
Nova Science Publishers Inc Opioids: Pharmacology, Clinical Uses & Adverse
Book Synopsis
£149.99
WW Norton & Co Lithium: A Doctor, a Drug, and a Breakthrough
Book SynopsisFrom insulin comas and lobotomy to incarceration; those who suffered bipolar disorder endured dangerous, ineffective treatments for centuries until a breakthrough in the 1950s offered salvation. Lithium’s efficacy at both ending and preventing manic depressive episodes was discovered by John Cade, whose years running a psychiatric ward as a prisoner of war sparked a hunch that put him on the path to revelation. The miraculous metal has since salvaged an untold number of lives but even after its healing power was discovered, it was decades before the medical community could be convinced that lithium was not only safe but life-saving. Walter A. Brown reveals how close we came to missing out on this extraordinary drug and showcasing the possibilities of scientific curiosity.Trade Review"The intertwined story of Cade and his momentous finding is told in Lithium, a compelling book by US psychiatrist Walter Brown... What Brown does superbly well is to show that Cade made his discovery without access to advances in technology or to modern facilities — and almost despite them." -- Nature"His [Walter Brown's] beautifully written and insightful book deserves to be widely read by poets and novelists, among whom instances of bipolar disorder are above average, and, more importantly, by all those involved in the regulation and provision of medicines." -- Literary Review
£13.29
Rockridge Press The 30-Minute Thyroid Cookbook: 125 Healing
Book Synopsis
£20.39
New Harbinger Publications Handbook of Clinical Psychopharmacology for
Book SynopsisA comprehensive resource for mental health professionals-now in a fully revised and updated tenth edition.
£51.00
Lulu.com Bag of Jokes - Psychiatrists Joke Too: Russian
Book Synopsis
£13.38
New Harbinger Publications Child and Adolescent Clinical Psychopharmacology
Book SynopsisA classic in its field, Child and Adolescent Clinical Psychopharmacology Made Simple offers everything you need to know about the use of psychoactive medications in the treatment of childhood and adolescent psychological disorders in easy-to-understand language.This fully revised and updated fourth edition offers new information on sleep disorders, sleep medication, and substance abuse. You’ll also find up-to-date DSM-5 definitions, information regarding teen use of antidepressants and suicidality, attention deficit/hyperactivity disorder (ADHD) and ADHD medications, bipolar disorder, psychotic episodes and eating disorders in children and adolescents, the use of antipsychotics in children and adolescents, non-medication approaches and adjuncts to medications, and how to assess and treat noncompliance and “breakthrough” symptoms.Also included are fact sheets that clearly delineate frequently prescribed medications for each disorder along with medication side effects and signs of toxicity. For each psychological disorder, the book offers: current diagnostic criteria; treatment indications and contraindications; medication information; and help for monitoring, evaluating, and following up with patients.Whether you are a pediatrician, parent, therapist, educator, or other health care professional, this is the only resource you need to consult for the most recent information on child and adolescent medications and treatment.
£22.00
Jessica Kingsley Publishers Psychiatric Medication and Spirituality: An
Book SynopsisChallenging an exclusively medical approach to mental health and illness, this book considers the impact psychiatric drugs can have on spirituality. In the last thirty years, a dramatic rise in medication as a treatment for mental illness has occurred in tandem with increasing numbers of people entering treatment with a spiritually-oriented understanding of their suffering. The unforeseen result is that some people taking psychiatric drugs are engaging with them in ways that can have a profound impact on the course and outcome of treatment. Based on interviews with people on psychiatric medication who regard spirituality as significant in their lives, this book reveals how medication can be perceived as both helpful and harmful to spirituality. The author argues that spirituality must be considered in debates around psychopharmacology.Trade ReviewSocietal debate about psychiatric drugs usually focuses on whether the drugs are "effective" or do more "good than harm". In this well-written, thoughtful book, Lynne Vanderpot explores the effects of psychiatric medications through a different lens: how do the medications affect one's subjective experience of being alive, and more particularly, one's internal experience of a spiritual life? Hers is a thoughtful, clear exploration of an important subject, and on every page her respect for the users of these medications and the diversity of their experiences shines through. -- Robert Whitaker, journalist and author of 'Anatomy of an Epidemic'Drawing on twenty compelling personal stories, Vanderpot attends to a fundamental, yet neglected problem - how and why psychiatric medications either enhance or inhibit healing spiritual responses to profound emotional suffering. The data highlight the troubling myopia of exclusively biological explanations and treatments of mental illness. Here you will learn just how a range of life contingencies differently shape our perceptions and experiences of pain, pills and personhood. Many readers, grabbed by its numerous striking insights, will themselves be transformed by this innovative volume. -- David A. Karp, Professor Emeritus of Sociology at Boston College and author of 'Is It Me or My Meds? Living with Antidepressants'Unlike doctors, people who take psychiatric medication measure the success of their treatment not just on clinical outcomes, but on how the drugs affect the totality of their lives. That includes spirituality-the search for meaning and purpose, as well as the feeling of connectedness to self, others, and the divine. Vanderpot's book is sensitively written and uniquely focused, a valuable addition to the conversation about the use of medication in the real world. -- Katherine Sharpe, author of Coming of Age on Zoloft (Harper Perennial, 2012)In exploring the relationship between spirituality and medication, Vanderpot invites both the prescribers of medication and the recipients of the medication to reflect more deeply on the person's life as a whole, a body-mind-spirit individual. To truly know a person in this way requires time. Unfortunately in the current limits of 15' medication sessions, a significant relationship cannot be established and the person suffers. All that is of value to them is not explored. Hopefully, this book can help us challenge the problems and dangers inherent in such limited encounters. -- Nancy Kehoe RSCJ, PhD, author of 'Wrestling with Our Inner Angels: Faith, Mental Illness and the Journey to Wholeness'Anyone interested in psychiatric medication and spirituality and how they interact in people's lives should read this excellent book. It is well researched and an easy and engaging read. It raises some truly important questions about how we view and treat human suffering including the impact of psychiatric medicine on the whole person. -- Professor William West, University of ChesterIn this thought-provoking book, Vanderpot makes the compelling case that the question of whether or not to use psychiatric drugs is more than simply a routine 'treatment' decision, but rather entails a sacred process of deep self-exploration. Drawing keen insights from the stories of those who have grappled deeply with this issue, Vanderpot invites us to consider the profound impact that psychiatric drug treatment has on the deepest levels of one's being, a question that becomes increasingly important as psychiatric drug use continues to escalate in the world today. -- Paris Williams, PhD., Clinical Psychologist and author of 'Rethinking Madness'Table of ContentsPrologue. 1. Hallowed be thy tablets. 2. Understanding Spirituality. 3. Understanding Psychopharmacology. 4. Medication Enhances Spirituality. 5. Medication Hinders Spirituality. 6. Rich Times for Rethinking the World. 7. Conclusion/Hope. Appendix.
£26.74
Imprint Academic Psychedelic Horizons
Book SynopsisThis is a different kind of book about psychedelics. Rather than describing psychedelic experiences, it presents four future-oriented ideas ''coming over the psychedelic horizon'', which illustrate the potential benefits of psychedelics for humanity: # Stanislav Grof''s view of our minds as a way to understand works of art (looking at Disney's Snow White). # The evidence that psychedelic-occasioned mystical experiences can boost our immune systems. # Psychedelics as a way of adding new cognitive programmes to our thinking skills. # Applying the ideas from Part 3 to learning.
£17.95
Wooden Books Altered States: Minds, Drugs and Culture
Book SynopsisWhat actually happens to you when you drink a cup of coffee?Is chocolate really an aphrodisiac? How do drugs like alcohol and cannabis work? Did psychedelics play a part in human evolution? In this fascinating little book, leading psychopharmacologist Dr. Ben Sessa describes the drugs, legal and illegal, natural and synthesised, from nicotine to endorphins, sugar to antidepressants, that humans all over the world take every day to change their state of mind. "Fascinating" FINANCIAL TIMES. "Beautiful" LONDON REVIEW OF BOOKS. "Rich and Artful" THE LANCET. "Genuinely mind-expanding" FORTEAN TIMES. "Excellent" NEW SCIENTIST. "Stunning" NEW YORK TIMES. Small books, big ideas.Table of ContentsIntroduction 1 States of Consciousness 2 The Brain 4 Neurotransmitters 6 Oxytocin & Adrenaline 8 Dreaming 10 Hypnotic States 12 Meditation 14 Endorphins 16 Sex & Aphrodisiacs 18 Emotional States 20 Food & Fasting 22 Sugar 24 Chocolate 26 Caffeine 28 Alcohol 30 Nicotine 32 Cannabis 34 Solvents & Inhalants 36 Ketamine & Nitrous Oxide 38 Cocaine 40 Opiates 42 MDMA & Amphetamines 44 Natural Psychedelics 46 LSD 48 Poisons & Potions 50 Shamanism 52 Antidepressants 54 Quantum Consciousness 56 Further Reading 58
£6.95
PCCS Books A Straight Talking Introduction to Psychiatric
Book SynopsisIn an era when more people are taking psychiatric drugs than ever before, Joanna Moncrieff's explosive book challenges the claims for their mythical powers. Drawing on extensive research, she demonstrates that psychiatric drugs do not 'treat' or 'cure' mental illness by acting on hypothesised chemical imbalances or other abnormalities in the brain. There is no evidence for any of these ideas. Moreover, any relief the drugs may offer from the distress and disturbance of a mental disorder can come at great cost to people's physical health and their ability to function in day-to-day life. And, once on these drugs, coming off them can be very difficult indeed. This book is a wake-up call to the potential damage we are doing to ourselves by relying on chemical cures for human distress. Its clear, concise explanations will enable people to make a fully informed decision about the benefits and harms of these drugs and whether and how to come off them if they so choose.Trade Review'This is a brilliant book. It offers an incisive, clear and evidence based appraisal of psychiatric drugs, arriving at just the right time to counter the growing controversy and confusion in this area. I could not think of a more respected and credible guide to take us through this tricky terrain. This book should be compulsory reading for anyone working in mental health. I would also recommend it for anyone holding a more personal interest in the subject.' - Dr James Davies, Reader in Social Anthropology & Mental Health, University of Roehampton, and author of Cracked: why psychiatry is doing more harm than good. 'There has never been a greater need for calm and reasoned thinking about psychiatric drug use, and, as a practising and open-minded psychiatrist, Joanna is the very best person to provide it. This book brings evidence and rationality to a contentious topic and offers people sound, researchbased information and genuine choice.' - Dr Lucy Johnstone, consultant clinical psychologist, author of A Straight Talking Introduction to Psychiatric Diagnosis and lead co-author of The Power Threat Meaning FrameworkTable of ContentsIntroduction, 1. The place of drug treatment in psychiatry, 2. How do psychiatric drugs work?, 3. The importance of research , 4. Antipsychotic drugs , 5. Antidepressants, 6. Lithium and other drugs used for bipolar disorder, 7. Stimulants, 8. Benzodiazepines, 9. Withdrawing from psychiatric drugs, 10. When might psychiatric drugs be useful? , 11. How did we get here and where do we go with it?, Appendix, Indexes
£14.24
Aeon Books Ltd The Psychedelic Renaissance: Reassessing the Role
Book SynopsisPraise for Second Edition of The Psychedelic Renaissance: 'Onward, intrepid explorer, keep your wits, while allowing them to be tickled, as Dr Sessa leads you into a world of remarkable wonders! You are in for a real treat!' Robin Carhart-Harris 'This new book is a succinct, entertaining overview of the emerging "Psychedelic Renaissance" written by an insider, and one of the brightest young architects of this new emerging paradigm.' Dr Dennis J. McKenna 'With intelligence, fact-based optimism and compassion Sessa throws open the doors of perception and guides the reader through the complexities of the history, pharmacology, legality and potential of these miraculous molecules.' Andy Roberts 'This new edition of Sessa's, The Psychedelic Renaissance, will encourage researchers to work in this field, to the benefit of our understanding of how the brain works and to develop new approaches to psychiatric disorders.' David Nutt 'Dr. Ben Sessa prescribes a way forward; mainstreaming psychedelics for a world in deep need of spirituality and inspiration. The Psychedelic Renaissance is a book that deserves to be widely read.' Rick Doblin 'Ben Sessa's energetic review of the research and cultural use of psychedelics provides a unique perspective. The way forward is clear: we urgently need more scientific research, and a rational reform of drug policies.' Amanda Feilding 'The Psychedelic Renaissance will inevitably and rightly be seen as an important marker of their assimilation into the cultural mainstream. I highly recommend it.' Ralph Metzner 'Dr. Sessa skilfully chronicles important developments, perhaps a turning point, in psychiatry and in the understanding of psychedelics in the wider culture. This new updated edition of The Psychedelic Renaissance is informative, entertaining and timely.' Michael MithoeferTable of ContentsForeword to 2017 Edition by Robin Carhart-Harris Introduction Chapter 1: Personal Reflection Chapter 2: The Experience and the Drugs Chapter 3: Early Pioneers of the First and Second Psychedelic Eras Chapter 4: The Prehistory and Ancient History of Hallucinogens Chapter 5: Hippie Heydays, Ravers and the Birth of Ecstasy Chapter 6: Psychedelic Creativity “Chapter 7: Modern Uses of Natural Plant and Fungi Psychedelics Chapter 8: The Psychedelic Renaissance Part One: Movers and Shakers Chapter 9: The Psychedelic Renaissance Part Two: Contemporary Studies Chapter 10: Psychedelics Caught in the Crossfire of the War on Drugs Conclusion Acknowledgments Notes Bibliography and Further Reading Index
£26.73
Critical Publishing Ltd Psychopharmacology: A mental health
Book SynopsisThis jargon-free guide is suitable for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes. A life-saving book that you can carry anywhere you go! Introductory material provides a background on psychotropic drugs, the etiology of mental illness, some of the commonly used drugs in practice and brief notes on common non-pharmacological interventional options. It also examines the pathophysiology of mental illness and clinical decision making. The central chapters provide comprehensive coverage of all the major medications used in the most common mental health disorders, detailing key drugs and including side effects, average doses, contra-indications and precautions, and clinical management interventions. Case studies, multiple choice questions and summary tasks in each chapter enable readers to clearly relate theory to practice and thoroughly review their learning. The second edition of this best-selling text has been completely revised to include: updated information and refreshed case studies throughout; more activities for self-study and interactive learning, including multiple choice questions; an emphasis on new ways of working within mental health settings, such as non-restrictive practice; a completely new chapter on alcohol and substance misuse. Trade ReviewI would recommend this book to all mental health nurse prescribers, nurses and students. The book layout is brilliant with a concise summary and questions at the end of each chapter, which makes the reader reflect on the content read in each chapter. A very well written and a very useful resource for practitioners and learners. -- Dr Geeta Patel (GP with specialist interest in psychiatry)Table of ContentsIntroduction 1. Mental illness and clinical decision making 2. Drugs used in psychoses 3. Drugs used in depression 4. Drugs used in dementia 5. Drugs used in bipolar disorders 6. Drugs used in anxiety disorders 7. Drugs used in alcohol and substance misuse Appendix- Answers to MCQs and chapter review questions Glossary References Index
£23.74
Waterside Press Brain and Mind Made Simple
Book SynopsisA stimulating account of interest to all students of neuroscience, psychiatry, psychology or biology — and of immense value to ‘first timers’ including undergraduates and A-level students. Written by one of the UK’s leading brain science experts, it traces the relationship between the ions, membranes and pumps of the brain and our thoughts, senses, feelings, impulses and consciousness. The book deals with such tantalising questions as: What are the ‘locks and keys’ of the brain? How does memory work and why do we forget? Why do we sleep, dream, and hopefully wake-up ready to go? How do fears, threats and nightmares penetrate our mental defences, or drugs, alcohol, psychedelics and medicines improve or hinder our thoughts, actions or behaviour? Are our eyes connected to the brain and why do we sometimes see things that aren’t there? Or hear ‘voices’? The book also explains how we can ‘see inside’ the brain, why we sometimes make a fool of ourselves, may have near death experiences and whether epilepsy is an ‘affliction of the Gods.’ Similarly what scientists know about the differences between delusion and schizophrenia; or the links between worry, anxiety, depression, mania and euphoria. It also covers obsession, stress and repetitive behaviour — just some of many topics dealt with within its revealing pages. An expert, scientific but simple guide.Table of ContentsThe Origins of Our Brains — Ions, Membranes and Pumps; Neurotransmitters and their Receptors — The Locks and Keys of Brain Function; The Tower of Complexity — How the Brain is Organized; The Vital Role of Subconscious Processing; How the Cortex Works — Seeing is Believing; Taking Control — From Urges to Self-discipline; Thinking, Feeling and Consciousness; The Emotional Brain; Getting Inside the Head — Surgery to Imaging Techniques; Sleep and Dreams; In Extremis — Near Death Experiences and Vegetative States; Affliction of the Gods? — Epilepsy; Darkness Visible? Depression; Why Worry? Fear and Anxiety Disorders; Delusional? Schizophrenia and Mania; Repetition, Obsession and Compulsion; From Pleasure to Pain? Addiction; Brain and Mind or Brain-v-Mind?; Selected Bibliography; Index.
£19.00
Muse House Press/Pennington Not Crazy: You May Not Be Mentally Ill
£9.45
Adventures Unlimited Press Liquid Conspiracy 2: The CIA, MI5 and Big
Book SynopsisUnderground author, Xaviant Haze, tackles the psychedelic underground and delves into the actions of the CIA and British Intelligence, with their mind control experiments and use of drugs such as LSD. Haze explores the pioneers of pyschodelia and the role of British Intelligence in spreading the use of LSD within the music industry. He looks into the CIA and its use of LSD as a mind control drug - at one point every CIA officer had to take the drug and endure mind control tests and interrogations to see if the drug worked as a truth serum. He looks into other truth serum drugs at the disposal of intelligence agencies such as scapolamine and asks: Why waterboarding? He looks at Big Pharma''s war on psychedelics and the healing powers that these drugs have. It''s a tour de force in search of the liquid conspiracy that still trickles down the alleyways. This is your government on drugs. Chapters include: The Pioneers of Psychedelia; The United Kingdom Mellows Out: The MI5, MDMA and LSD; Taking it to the Streets: LSD becomes Acid; Great Works of Art Inspired and Influenced by Acid; Scapolamine: The CIA''s Ultimate Truth Serum; Mind Control, the Death of Music and the Meltdown of the Masses; Big Pharma''s War on Psychedelics; The Healing Powers of Psychedelic Medicine and tons more.
£18.70
Wooden Books Altered States: Minds, Drugs and Culture
Book Synopsis
£8.50
Wolters Kluwer Health Green's Child and Adolescent Clinical
Book SynopsisThe sixth edition of this classic text continues to provide clinically-oriented information on medications used to treat common mental health conditions and disorders in children and adolescents. The book boasts an accessible style—with even more tables, graphs, and clinical pearls than ever before—that is designed for easy reading and comprehension. Substantially updated with expanded medication coverage for new FDA approved indications, this practical guide is perfect for residents and practitioners in psychiatry and pediatrics, as well as family medicine. Emphasizes new and highly used medications and discusses FDA-approved and off-label usage. Adds new chapters on de-prescribing and managing substance use disorders in adolescents. Beefs up coverage of injectable medications and third-generation anti-psychotics as well as weight stabilization medications. Prominently displays precautions and warnings to mitigate prescribing errors and adverse interactions. Enhance Your eBook Reading Experience: Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech. Trade ReviewIn this sixth edition of a practical and well-organized guide to psychopharmacology in children and adolescents, the authors provide updated evidence and guidelines for the clinical use of psychotropic medications as well as added information about medications more recently accepted for use with pediatric populations. This edition aims to provide practical clinical information about the evidence for the prescribing of psychotropic medications for children with mental health disorders, while keeping an open mind to nonpharmacological treatments in a psycho-social-cultural context. Well-organized guidelines for dose-titration, maintenance, discontinuing, and even de-prescribing occupy the bulk of this book. The book is intended primarily for clinicians who are actively participating in treating children and adolescents with psychotropic medications for mental health disorders. Specifically, psychiatrists (both general and child and adolescent), pediatricians, family medicine doctors, psychologists with prescribing privileges, physician assistants, nurse practitioners, and advanced practice nurses all could benefit from this book. Trainees including medical and nursing students also would likely find this book helpful. The first of the book's two main sections introduces general principles of diagnosing and treating psychiatric illness in the pediatric population and provides some very useful flowcharts for treatment options for various disorders common to children and adolescents. The second section is much more comprehensive and presents clinically relevant information about prescribing, titrating, discontinuing, and monitoring of specific medications, divided into general drug classes. The book also includes practical tips for managing adverse effects, including strategies to prevent or reverse metabolic changes such as obesity in children on psychotropic medications. As in previous editions, the book continues to outline FDA black box and bold print warnings, specific indications, and outlines of landmark research pertaining to the medications. For medications commonly used for non-FDA-approved indications, this book outlines the available evidence for off-label use as well. The book is neatly organized, featuring intuitive charts, tables, and highlighted pearls, in addition to paragraph-form discussion. One thing this book does not include is more in-depth information about the pharmacokinetics/pharmacodynamics of most drugs, information that can be obtained in more comprehensive psychopharmacology books. This is a pragmatic and succinct guide for clinicians prescribing psychotropic medications to children and adolescents. As a reference, the book is easy to use and well organized. This edition has added information about new psychotropic medications as well as new formulations and uses for medications included in previous editions. For readers who prefer a hybrid of quick-and-dirty charts and tables plus more in-depth clinical information, this book would make a good addition to their office book collection. Weighted Numerical Score: 86 - 3 Stars
£76.50
Wolters Kluwer Health Winter's Basic Clinical Pharmacokinetics
Book SynopsisPopular among students and clinicians for its easy-to-read, case-study format, Winter’s Basic Clinical Pharmacokinetics, 7th Edition, clarifies complex concepts to help you confidently apply pharmacokinetics and therapeutic drug monitoring to patient care. This straightforward text is divided into two parts, reviewing basic pharmacokinetic principles in Part I and illustrating the clinical application of these principles to the most commonly encountered problems in Part II. The significantly updated and expanded 7th Edition adds essential coverage of the use of pharmacokinetics in managing obesity, pregnancy, as well as anticoagulation. NEW! Chapters unique to this 7th Edition equip students with proven pharmacokinetic approaches to obesity, pregnancy, and anticoagulation. Straightforward two-part format reinforces fundamental concepts and related clinical applications to ensure an advanced-level mastery. Case-based approach, similar to Applied Therapeutics, cultivates essential clinical reasoning capabilities. Detailed drug monographs familiarize students with the most commonly prescribed drugs for a wide range of problems and conditions.
£70.20
Createspace Independent Publishing Platform Antabuse Treatment For Alcoholism
£14.38
Springer Verlag GmbH Lehrbuch Psychiatrie
Book SynopsisDas Lehrbuch listet die Krankheitsbilder anhand der ICD-10-Klassifikationen auf und stellt die psychischen Störungen hinsichtlich ihrer Epidemiologie, Psychopathologie, Ätiologie und Diagnostik, aber auch neuartiger Therapiekonzepte dar. Viele Fallbeispiele dienen dabei der Vertiefung und helfen bei der Einprägung des Stoffs. Eingeflossen sind neueste Forschungsergebnisse aus der Pharmakologie, Psychotherapie und biologischen Psychiatrie. Das Lehrbuch begleitet die Einarbeitung in das Fachgebiet während des Studiums oder in der Facharztausbildung.Trade Review“... Untermauert werden die jeweiligen Themen mit Diagrammen, Tabellen und etwaigen Fallbeispielen. Am Ende jedes Kapitels sind Vorschläge für weiterführende Literatur zu den jeweiligen Störungen aufgelistet. ... Sehr hilfreich ist das Glossar am Ende des Buches mit Erklärungen vieler psychiatrischer und psychopathologischer Fachausdrücke. ... Dieses Buch ist geeignet für Medizinstudenten, die sich tief in die Thematik einarbeiten wollen. ... Es geht sehr ins Detail und ist so umfassend, dass es für Assistenten in der Weiterbildung, Ärzte, Psychologen, Psychotherapeuten empfehlenswert ist.” (in: Fachschaft Medizin LMU München, fachschaft-medizin.de, Dezember 2015)“... zahlreiche Tabellen, die verschiedenste Sachverhalte ... der Schreibstil ist sehr angenehm und leicht verständlich ... Das Buch ist besonders für Medizinstudierende in ... sehr empfehlenswert ...“ (Thomas Schütz, in: Medizinische Universität Innsbruck, skalpell.at,11.März 2015)“... Zielgruppe: Medizinstudenten, Assistenten in der Weiterbildung, Ärzte, Psychologen, Psychotherapeuten ... Das Lehrbuch Psychiatrie ist für Studierende der Medizin durchaus empfehlenswert, wenn auch sehr umfangreich. ... Wer in das Gebiet der Psychiatrie ein bisschen tiefer einsteigen möchte, ist mit diesem Lehrbuch bestimmt gut beraten.“ (in: Fachschaft Medizin Marburg, fs-medizin.de, 30. März 2015)“… Die Informationen im Buch werden ergänzt durch Tabellen und Flussdiagramme, welche komplizierte Sachverhalte erleichtern und bei Behandlungsschemata die zeitliche Reihenfolge. Auch Kategorisierungen und Klassifikationen werden durch die Nutzung von Tabellen deutlich überischtlicher. ... einen strukturierten und detaillierten Einstieg in die Psychiatrie bekommen, welcher außerdem viel Wert auf klinische Bezüge legt ...“ (in: Fachschaft Medizin Münster, fsmed-muenster.de, 2.Januar 2015) “... der Aufbau ist gut gelungen, man findet schnell und übersichtlich alle Informationen oder Stichworte, die man sucht. ... Die meisten relevanten Themen sind enthalten und auch sehr gut erklärt. ...“ (in: Veasyte, S 62, Wintersemester 2014-2015)“... überarbeitete und aktualisierte Lehrbuch richtet sich an Studierende der Medizin sowie an in Ausbildung befindlichen Psychiaterinnen, Psychologinnen und Psychotherapeutinnen, aber auch an bereits Praktizierende sowie an Vertreterinnen der Nachbardisziplinen Neurologie, Innere Medizin, Pädiatrie, Pädagogik und Pflegewissenschaften ... die Komplexität des Fachgebiets in leichtverständlicher, aber gleichzeitig spannender Form darstellen ...” (Anita Riecher-Rössler, in: Schweizer Archiv für Neurologie und Psychiatrie, Swiss Archives of Neurology & Psychiatry, 2014, Vol. 165, Issue 1, S. 33)Table of Contents Einführung Organische einschließlich symptomatischer psychischer Störungen Psychische und Verhaltensstörungen durch psychotrope Substanzen Schizophrenie, schizotype und wahnhafte Störungen Affektive Störungen Neurotische Belastungs- und somatoforme Störungen Verhaltensauffälligkeiten mit körperlichen Störungen und Faktoren Essstörungen nicht organische Schlafstörungen nicht organische sexuelle Funktionsstörungen psychische und Verhaltungsstörungen im Wochenbett Missbrauch von nicht abhängigkeitserzeugenden Substanzen Persönlichkeits- und Verhaltensstörungen Kinder- und Jugendpsychiatrie Gerontopsychiatrie Suizidales Verhalten Schmerz Psychiatrische Notfall Psychotherapeutische Verfahren Grundzüge der Sozialpsychiatrie Psychiatrische Rehabilitation Grundzüge der Konsilliar/Liaison Psychiatrie Forensische Psychiatrie
£52.24
Springer International Publishing AG The Neuropharmacology of Alcohol
Book SynopsisThis volume gives an overview of new insights to alcohol pharmacology using DREADDs (Designer Receptors and Unraveling the Neuropharmacology of Alcohol). It examines which pharmacological principles should be applied to understanding DREADDs taking into account some very current research. Additionally, this book covers important topics under the heading of “experimental pharmacology” and alcohol.Table of ContentsPart 1. Neurotransmitter systems.- 1. GABAA receptor subtype mechanism and the abuse related effects of ethanol: Genetic and pharmacological evidence.- 2. Presynaptic Ethanol Actions: Potential Roles in Ethanol Seeking.- 3. Dynamic adaptation in neurosteroid networks in response to alcohol.- 4. GABA and Glutamate synaptic co-adaptations to chronic ethanol in the striatum.- 5. The cerebellar GABAAR system as a potential target for treating alcohol use disorder.- 6. Do alcohol-related AMPA-type glutamate receptor adaptations promote intake?.- 7. Molecular, neuronal and behavioral effects of ethanol and nicotine interactions.- 8. Cross-species alterations in synaptic dopamine regulation after chronic alcohol exposure.- 9. Central noradrenergic interactions with alcohol and regulation of alcohol related behaviors.- Part 2. Ion Channels.- 10. Voltage-sensitive calcium channels in the brain: Relevance to alcohol intoxication and withdrawal.- 11. Voltage-sensitive potassium channels of the BK type and their coding genes are alcohol targets in neurons.- 12. Chronic alcohol, intrinsic excitability, and potassium channels: Neuroadaptations and drinking behavior.- Part 3. Neuroimmune system.- 13. Hepatic immune system adaptations to alcohol.- 14. Innate immune signaling and alcohol use disorders.- 15. Cytokins in the CNS.- Part 4. Neuropeptides and Genomics.- 16. Corticotropin Releasing Factor (CRF) Neurocircuitry and neuropharmacology in alcohol drinking.- 17. Contribution of dynorphin and orexin neuropeptide systems to the motivational effects of alcohol.- 18. Transcriptional regulators as targets for alcohol pharmacotherapies.- Part 5. Pharmacotherapy.- 19. Advances in Pharmacotherapy Development From Preclinical Animal Studies.- 20. Advances in Pharmacotherapy Development: Human Clinical Studies.
£179.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Pflegewissen Psychopharmaka
Book SynopsisMehr als nur Aufbewahren, Richten und Verabreichen: verantwortungsvoll Pflegen!Dieses Buch richtet sich an Pflegende im ambulanten und stationären Bereich und bietet wichtiges Fachwissen über Psychopharmaka. Welches sind die wesentlichen Merkmale der einzelnen Medikamentengruppen? Was sind die Wirkmechanismen, Neben- und Wechselwirkungen und wie geht man therapeutisch vor? Hier benötigen Pflegende eine gute Basiskompetenz, denn es bestehen viele Vorurteile und Halbwahrheiten gegenüber den am meisten verordneten Medikamenten. Kontinuierliche Krankenbeobachtung und eine frühzeitige Informationsweitergabe gehören ebenso zu der Verantwortung, wie das korrekte Aufbewahren, Richten und Verabreichen. Die einheitliche Struktur des Buches bietet eine gute Übersicht der unterschiedlichen Gruppen und pflegerischen Besonderheiten. Table of ContentsI Allgemeiner Teil: Einführung, Was sind Psychopharmaka?, Wie wirken Psychopharmaka?, Psychopharmaka - wann und für wen?, Compliance (Einnahmezuverlässigkeit) und Patienteninformation, Welche Neben- und Wechselwirkungen sind wichtig?, Kontrolluntersuchungen, Psychopharmaka und Lebensqualität, Psychopharmaka bei körperlichen Krankheiten, Sucht – Machen Psychopharmaka abhängig?, Wie werden Psychopharmaka sinnvoll kombiniert, umgestellt oder abgesetzt?, Psychopharmaka in Schwangerschaft und Stillzeit, Psychopharmaka bei Kindern und Jugendlichen, Psychopharmaka im Alter, Pflegerische Aspekte.- II Spezieller Teil: Antidepressiva, Stimmungsstabilisierer, Antipsychotika (Neuroleptika), Tranquilizer (Beruhigungsmittel), Hypnotika (Schlafmittel), Antidementiva, Psychostimulanzien, Entzugs- und Entwöhnungsmittel.
£26.59
Argonowta Digital Essential guide to the Psychedelic Renaissance:
Book SynopsisLearn all the basics of psychedelics and why all this research is great news for public health in this century.After a very long and strange journey, psychedelics may finally be back for good. Rick Doblin, PhD, Founder & Executive Director, MAPS. In the guide you will learn all the essentials about the history, neuroscience, legality, therapeutic applications and harm reduction of the most promising psychedelic drugs for science. After decades of international prohibition these molecules are returning to laboratories and clinics, hand in hand with the most rigorous science, to revolutionize the way we understand and treat mental health (depression, anxiety, PTSD and addictions). Discover the world of psilocybin, MDMA, DMT, ketamine and LSD, before society immerses in this revolution, which will forever change the perception we have of psychedelics. This guide will be of interest to both therapists and other mental health professionals interested in the clinical applications, parents and educators seeking to understand the impact and safety of psychedelics and other drugs, as well as any adult curious to learn about and explore this new world of the psychedelic renaissance.
£20.69
World Health Organization Neuroscience of Psychoactive Substance Use and
Book Synopsis
£51.65
Thieme Medical Publishers Principles and Practice of
Book Synopsis
£45.90
World Scientific Publishing Co Pte Ltd Pharmacotherapy For Depression And
Book SynopsisThis unique ground-breaking work, authored by renowned Harvard-based researchers G I Papakostas and M Fava, represents, by far, the most comprehensive compilation to date of medical studies and reports involving the use of antidepressants for the treatment of major depressive disorder, one of the most prevalent and devastating medical illnesses afflicting mankind today. Given the breadth of the scientific literature focusing on the use of antidepressants for major depressive disorder, this work represents an invaluable tool for clinicians as well as scientists in search of a reference manual to help guide them through the field. The book is organized into four parts; each part focusing on a separate theme that will facilitate the reader to precisely access particular information of interest, whether be it clinical or scientific in nature. Each part is then sub-divided into several thematic chapters, which are enriched with tables and figures citing results from the most influential studies in the field. Finally, clinical and research “pearls” are listed throughout the book in bullet-point fashion to help summarize the available knowledge-base in a user-friendly format.Table of ContentsMajor Depressive Disorder and Treatment-Resistant Depression; First-Line Pharmacotherapy Strategies: Monoaminergic-Based Strategies: Single-ActingA" Agents; Monoaminergic-Based Strategies: Dual-ActingA" Agents; Monoaminergic-Based Strategies: Triple-ActingA" Agents; Polypharmacy from the Onset of Treatment; Next-Step Treatment Strategies: Polypharmacy Strategies for Treatment-Resistant Depression; Monotherapy Strategies for Resistant Depression; Maintaining Treatment Gains: Pharmacotherapy of Relapse/Recurrence Prevention and Treatment; Pharmacologic Strategies to Enhance Antidepressant Tolerability; Non-pharmacologic Approaches for Resistant Depression; Future Directions in Treatment Development: Agents Operating on Non-monoaminergic Neurotransmitter Systems; Neuroendocrine Agents; Metabolic-Based and Other Agents; Biological Predictors, Moderators, and Mediators of Efficacy.
£207.00
Hong Kong University Press Coaching Intervention for Psychosis – A Lifestyle
Book Synopsis
£19.80